Total Payments
$804.46
2024 Payments
$159.64
Companies
19
Transactions
46
Medicare Patients
970
Medicare Billing
$47,121
Payment Breakdown by Category
Food & Beverage$804.46 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $804.46 | 46 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lundbeck LLC | $93.73 | 5 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $81.51 | 4 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $72.54 | 4 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $66.17 | 4 | $0 (2023) |
| PFIZER INC. | $62.32 | 4 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $59.60 | 4 | $0 (2022) |
| Amgen Inc. | $56.47 | 3 | $0 (2024) |
| GlaxoSmithKline, LLC. | $55.40 | 3 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $48.63 | 3 | $0 (2022) |
| Novo Nordisk Inc | $47.39 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $159.64 | 8 | Lundbeck LLC ($70.78) |
| 2023 | $218.90 | 12 | Bayer Healthcare Pharmaceuticals Inc. ($35.13) |
| 2022 | $178.73 | 11 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($35.92) |
| 2021 | $125.47 | 7 | Novo Nordisk Inc ($35.12) |
| 2019 | $47.52 | 3 | PFIZER INC. ($17.39) |
| 2018 | $74.20 | 5 | PFIZER INC. ($32.54) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/19/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: EndoVenous Therapies | ||||||
| 07/24/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $26.79 | General |
| Category: RESPIRATORY | ||||||
| 07/22/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.67 | General |
| Category: PSYCHIATRY | ||||||
| 07/16/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Inflammation | ||||||
| 03/21/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.56 | General |
| Category: PSYCHIATRY | ||||||
| 02/05/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.63 | General |
| Category: PSYCHIATRY | ||||||
| 01/08/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.92 | General |
| Category: PSYCHIATRY | ||||||
| 12/13/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: RESPIRATORY | ||||||
| 12/07/2023 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $29.06 | General |
| Category: Transcatheter Heart Valves | ||||||
| 10/31/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.95 | General |
| Category: PSYCHIATRY | ||||||
| 10/17/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/04/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Inflammation | ||||||
| 06/28/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE, XIFAXAN | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Gastroenterology | ||||||
| 04/12/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Gastroenterology | ||||||
| 04/05/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Cardio-renal | ||||||
| 03/08/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: NEUROSCIENCE | ||||||
| 02/22/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Inflammation | ||||||
| 02/01/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Cardio-renal | ||||||
| 01/23/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Diabetes | ||||||
| 11/29/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Cardio-renal | ||||||
| 10/26/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Gastroenterology | ||||||
| 10/26/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Gastroenterology | ||||||
| 06/29/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.47 | General |
| Category: Cardiovascular | ||||||
| 05/23/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.74 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 510 | 617 | $124,518 | $25,824 |
| 2022 | 9 | 404 | 479 | $94,405 | $18,395 |
| 2021 | 4 | 56 | 57 | $8,733 | $2,902 |
Total Patients
970
Total Services
1,153
Medicare Billing
$47,121
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 101 | 176 | $54,600 | $8,109 | 14.9% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 22 | 22 | $3,440 | $3,146 | 91.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 40 | 41 | $3,665 | $2,942 | 80.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 53 | 66 | $14,850 | $2,719 | 18.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 98 | 98 | $23,618 | $1,750 | 7.4% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 36 | 36 | $3,960 | $1,510 | 38.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 41 | 42 | $2,436 | $1,322 | 54.3% |
| 77067 | Screening mammography | Office | 2023 | 12 | 12 | $3,924 | $1,194 | 30.4% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 22 | 22 | $2,120 | $922.90 | 43.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 18 | $7,825 | $846.70 | 10.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 11 | 11 | $638.00 | $346.17 | 54.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 26 | 35 | $1,260 | $325.30 | 25.8% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 12 | 12 | $804.00 | $310.68 | 38.6% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 11 | 13 | $780.00 | $240.12 | 30.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 13 | $598.00 | $140.63 | 23.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 92 | 144 | $43,200 | $6,540 | 15.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 43 | 44 | $3,530 | $2,944 | 83.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 55 | 65 | $14,625 | $2,364 | 16.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 74 | 74 | $17,834 | $1,804 | 10.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 44 | 45 | $2,610 | $1,377 | 52.8% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 33 | 33 | $3,630 | $1,338 | 36.9% |
| 0004A | Adm sarscov2 30mcg/0.3ml bst | Office | 2022 | 24 | 24 | $1,730 | $964.46 | 55.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 14 | $5,950 | $718.45 | 12.1% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 25 | 36 | $1,296 | $345.26 | 26.6% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 16 | 16 | $1,280 | $1,044 | 81.6% |
About Dr. Craig Davis, MD
Dr. Craig Davis, MD is a Internal Medicine healthcare provider based in Gresham, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508975715.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Craig Davis, MD has received a total of $804.46 in payments from pharmaceutical and medical device companies, with $159.64 received in 2024. These payments were reported across 46 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($804.46).
As a Medicare-enrolled provider, Davis has provided services to 970 Medicare beneficiaries, totaling 1,153 services with total Medicare billing of $47,121. Data is available for 3 years (2021–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Gresham, OR
- Active Since 08/30/2006
- Last Updated 09/30/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1508975715
Products in Payments
- REXULTI (Drug) $93.73
- Kerendia (Drug) $81.51
- XIFAXAN (Drug) $66.17
- ELIQUIS (Drug) $59.60
- Otezla (Drug) $56.47
- XARELTO (Drug) $48.63
- Ozempic (Drug) $47.39
- LYRICA (Drug) $33.22
- BREZTRI (Drug) $29.80
- SAPIEN 3 Ultra RESILIA (Device) $29.06
- AREXVY (Drug) $26.79
- FARXIGA (Drug) $26.54
- VENASEAL (Device) $21.51
- CHANTIX (Drug) $16.71
- BYDUREON (Drug) $16.20
- CONTRAVE (Drug) $16.17
- VOQUEZNA (Drug) $16.06
- MOUNJARO (Drug) $15.87
- SHINGRIX (Biological) $15.06
- LONHALA MAGNAIR (Drug) $13.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Gresham
Edward Cheng, M.d,, M.D,
Internal Medicine — Payments: $39,176
Internal Medicine $39,176
Dr. Avnish Tripathi, M.d., Ph.d., M.p.h, M.D., PH.D., M.P.H
Internal Medicine — Payments: $12,554
Internal Medicine $12,554
Jennifer Rodriguez, M.d, M.D
Internal Medicine — Payments: $10,858
Internal Medicine $10,858
Steven Maness, M.d, M.D
Internal Medicine — Payments: $6,102
Internal Medicine $6,102
Angela Gibbs, Md, MD
Internal Medicine — Payments: $1,551
Internal Medicine $1,551
Shanna Cheng
Internal Medicine — Payments: $510.26
Internal Medicine $510.26